Novo Nordisk, the world leader in diabetes care is recognized as one among the top ethical companies in the world according to Ethisphere study. The analysis is based on the sustainable and ethical leadership of the Denmark drug major.

More than 10,000 of the world's leading companies were analyzed for a period of six months in six continents, across 35 industries before arriving at the final list. These companies were evaluated on seven key parameters which included corporate responsibility, governance, innovation leadership, integrity track record, internal systems programme before deciding on the final list.

According to Ethisphere, the list recognizes companies that go beyond making statements about doing business 'ethically but are able to translate into action and demonstrate real and sustained ethical leadership within their industries'.

Novo Nordisk is a world leader in diabetes care, haemostasis management, growth hormone therapy and hormone replacement therapy. The Denmark-based company employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries.